BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3622372)

  • 1. Stereochemistry of the functional group determines the mechanism of aromatase inhibition by 6-bromoandrostenedione.
    Osawa Y; Osawa Y; Coon MJ
    Endocrinology; 1987 Sep; 121(3):1010-6. PubMed ID: 3622372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active-site-directed inactivation of aromatase from human placental microsomes by brominated androgen derivatives.
    Bellino FL; Gilani SS; Eng SS; Osawa Y; Duax WL
    Biochemistry; 1976 Oct; 15(21):4730-6. PubMed ID: 974087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human placental aromatase in a perfusion model. Comparison with kinetic, cell-free experiments.
    Klein H; Bartsch W; Niemand A; Stürenburg HJ; Voigt KD
    J Steroid Biochem; 1988 Feb; 29(2):161-9. PubMed ID: 3347056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of human placental aromatase by 6 alpha- and 6 beta-hydroperoxyandrostenedione.
    Tan L; Petit A
    Biochem Biophys Res Commun; 1985 Apr; 128(2):613-20. PubMed ID: 3994715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme interactions of 2,10-ethanoandrostene-3,17-dione: aromatase and 17 beta-hydroxysteroid dehydrogenase.
    Greway AT; Mentzer M; Levy MA
    Biochem Int; 1990; 20(3):591-7. PubMed ID: 2161228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroperoxides as inactivators of aromatase: 10 beta-hydroperoxy-4-estrene-3,17-dione, crystal structure and inactivation characteristics.
    Covey DF; Hood WF; Beusen DD; Carrell HL
    Biochemistry; 1984 Nov; 23(23):5398-406. PubMed ID: 6509027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of a new series of mechanism-based aromatase inhibitors.
    Lesuisse D; Gourvest JF; Hartmann C; Tric B; Benslimane O; Philibert D; Vevert JP
    J Med Chem; 1992 May; 35(9):1588-97. PubMed ID: 1578485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aromatase inhibition by 4-thiosubstituted-4-androstene-3,17-dione derivatives.
    Abul-Hajj YJ
    J Steroid Biochem; 1990 Jan; 35(1):139-43. PubMed ID: 2308324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competitive inhibition and suicide inactivation of human placental aromatase by androst-4-ene-3,6-dione derivatives and 3 alpha-methoxyandrost-4-ene-6,17-dione.
    Numazawa M; Mutsumi A; Kigawa H
    Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3076-80. PubMed ID: 2085891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androst-5-ene-7,17-dione: a novel class of suicide substrate of aromatase.
    Numazawa M; Mutsumi A; Hoshi K; Tanaka Y
    Biochem Biophys Res Commun; 1992 Jul; 186(1):32-9. PubMed ID: 1632774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tritium release from [19-3H]-19,19-difluoroandrost-4-ene-3,17-dione during inactivation of aromatase.
    Furth PS; Robinson CH
    Biochemistry; 1989 Feb; 28(3):1254-9. PubMed ID: 2653438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependent inhibition of human placental aromatase with a 2,19-methyleneoxy-bridged androstenedione.
    Peet NP; Burkhart JP; Wright CL; Johnston JO
    J Med Chem; 1992 Aug; 35(17):3303-6. PubMed ID: 1507213
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the mechanism of action of the aromatase inhibitor, 4-hydroxyandrostenedione.
    Abul-Hajj YJ
    Steroids; 1983 Jun; 41(6):783-90. PubMed ID: 6665821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
    Kellis JT; Vickery LE
    Endocrinology; 1984 Jun; 114(6):2128-37. PubMed ID: 6723577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme inactivation by potential metabolites of an aromatase-activated inhibitor (MDL 18,962).
    Johnston JO; Wright CL; Holbert GW; Benson HD
    J Enzyme Inhib; 1990; 4(2):137-42. PubMed ID: 2098520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics.
    Reidy GF; Mehta I; Murray M
    Mol Pharmacol; 1989 May; 35(5):736-43. PubMed ID: 2725477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of bromoacetoxy 4-androsten-3-ones as active site-directed inhibitors of human placental aromatase.
    Numazawa M; Tsuji M; Osawa Y
    Steroids; 1986; 48(5-6):347-59. PubMed ID: 3445287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competitive inhibition of human placental aromatase by N-n-octanoylnornicotine and other nornicotine derivatives.
    Bullion K; Ohnishi S; Osawa Y
    Endocr Res; 1991; 17(3-4):409-19. PubMed ID: 1811989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatase inhibition by 7-substituted steroids in human choriocarcinoma cell culture.
    Brueggemeier RW; Katlic NE; Kenreigh CA; Li PK
    J Steroid Biochem Mol Biol; 1992 Jan; 41(1):85-90. PubMed ID: 1734938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiol-containing androgens as suicide substrates of aromatase.
    Bednarski PJ; Porubek DJ; Nelson SD
    J Med Chem; 1985 Jun; 28(6):775-9. PubMed ID: 4009599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.